Two-dose Gardasil
In Clinical
Follow this topic
Bookmark
Record learning outcomes
The EC has granted marketing authorisation for a two-dose schedule (0 and 6 months) of the quadrivalent human papillomavirus vaccine Gardasil in children aged nine to 13 years.